Dr. Hennings started his pharmaceutical career as a preclinical research associate at ZYMA, a Ciba-Geigy company, where he progressed through various roles of increasing responsibilities. He then moved to Boehringer-Ingelheim as a Director, Corporate Regulatory Affairs, and was later appointed Vice-President, European Regulatory Affairs at Hoechst-Marion-Roussel (HMR), with the responsibility for European Regulatory Affairs, Pharmacovigilance & Compliance (GMP, GLP, GCP).
He started his own consultancy in Regulatory Sciences in October 2002. His experience covers the management of Research, Development, and Medical & Regulatory functions for European and world-wide registration of New Active Substances, Medical Devices, Line Extensions and national & EU referral procedures.
He holds the qualification as Qualified Person (QP) according article 49 of Directive 2001/83/EC.
Dr. Hennings holds a PhD degree in Biochemical Pharmacology from the University of Munich and the Max-Planck Institute for Biochemistry in Munich, Germany.